CMIT News
Read the latest news from research, studies, to clinical trials taking place at CMIT.
Potential of Molecular Imaging to Advance Molecular Medicine
By Pradeep K. Garg, PhDExecutive Director, Center for Molecular Imaging and Therapy Molecular imaging is a technology that allows for non-invasive interrogation of physiological and biochemical processes in the body. Over the years, the use of Molecular Imaging is on...
CMIT Executive Director Dr. Pradeep Garg team publish PET imaging study on nicotine distribution
A recent study published by Dr. Pradeep Garg, Executive Director of the Center for Molecular Imaging and Therapy (CMIT) in Shreveport, explores the distribution of nicotine in the human body. Adult smoking in the United States has decreased substantially since the...
Center for Molecular Imaging and Therapy study shows promise for better detection of melanoma
A recently published study by BRF’s Center for Molecular Imaging and Therapy (CMIT) Executive Director Dr. Pradeep K. Garg and his research team focuses on developing a novel radiopharmaceutical that shows promise in helping the medical community more effectively...
CMIT manufactures PET radiopharmaceuticals to detect neurodegenerative diseases
CMIT has signed a six-year contract with Eli Lilly/ AVID to produce a PET radiopharmaceutical for early detection of Alzheimer’s disease. The compound, F-18 labeled AV-1451, targets the brain’s tau protein that is one of the leading culprits in several...
BRF leading innovation in molecular imaging and research through new Center for Molecular Imaging and Therapy
BRF is leading innovation in molecular imaging and research in Louisiana through a new $14.2 million, 20,000 sq. ft. Center for Molecular Imaging and Therapy (CMIT). To secure the CMIT project, the State of Louisiana offered BRF a competitive incentive package that...